About BrainHealth
BrainHealth is an EU-funded cross-border collaboration (Interreg SK-AT) focused on preventing neurodegenerative diseases by examining how nutrition and structured physical activity can promote healthy brain ageing and inform evidence-based prevention strategies.
Neurodegenerative diseases, especially Parkinson’s, Alzheimer’s, and other dementias, remain largely incurable and are closely tied to biological aging; late diagnosis and limited understanding of underlying mechanisms hinder effective interventions, and long preclinical phases underscore the need for early biomarkers and preventive strategies.
BrainHealth studies potential early biomarkers in older, mostly healthy adults without evident cognitive impairment. It examines links between cognitive performance and structured resistance training, alongside a combined supplementation with omega-3 fatty acids, phosphatidylserine, and creatine monohydrate.
Background & Project Aim
-
Background
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other forms of dementia are closely linked to biological ageing and remain largely incurable.
One major challenge is that these diseases often develop over long preclinical phases, during which pathological changes accumulate before clinical symptoms become apparent. This makes early prevention and the identification of potential biomarkers especially important.
-
Project Aim
BrainHealth aims to investigate early potential biomarkers of age related neurodegenerative diseases in older, predominantly healthy adults without apparent cognitive impairment. The project focuses on the relationship between cognitive performance, physical activity, especially structured resistance training, and targeted supplementation with omega 3 fatty acids, phosphatidylserine, and creatine.
Why Brain Health matters
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other forms of dementia are closely linked to biological ageing and are still largely incurable. The development of effective therapies is limited by an incomplete understanding of the underlying molecular and cellular mechanisms.
Neurodegenerative diseases develop over long preclinical phases. During this time, pathological processes may accumulate unnoticed before clinical symptoms become visible. This highlights the importance of early prevention and early detection.
A central aim of BrainHealth is to investigate early potential biomarkers associated with neurodegeneration and brain ageing. Identifying such biomarkers is challenging because biological factors, lifestyles, and health related conditions can vary greatly between individuals.
The project focuses on nutrition and physical activity as central factors in the prevention of neurodegenerative diseases. In particular, the study examines structured resistance training and targeted supplementation in relation to cognitive performance in older adults.
Explore resources and ways to get involved